Sublingual immunotherapy

The sublingual immunotherapy (SLIT) practice parameters contain systematically developed statements with recommendations intended to optimize patient care and assist physicians and/or other health care practitioners and patients to make decisions regarding this therapy. This guideline is based on 2 published systematic reviews of the literature1,2 and publications identified by the workgroup's comprehensive literature search and the US Food and Drug Administration (FDA)–approved SLIT tablets' product information.

http://ift.tt/2mnWQII